Tesofensine

Tesofensine is a drug originally developed for the treatment of Alzheimer’s and Parkinson’s diseases, but it gained significant attention for its potential as a weight loss medication. The drug works primarily as a triple reuptake inhibitor, blocking the reuptake of the neurotransmitters serotonin, dopamine, and noradrenaline. This action increases the levels of these neurotransmitters in the brain, which can lead to reduced appetite and increased metabolism.

Clinical trials of tesofensine have shown that it can lead to significant weight loss in obese individuals, often more than what is seen with currently available weight loss drugs. However, the development of tesofensine for obesity has also highlighted potential side effects such as increased heart rate, high blood pressure, nausea, and insomnia.